Recent Advances in Tuberculosis and Nontuberculous Mycobacteria Lung Disease / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
;
: 251-255, 2013.
Artículo
en Inglés
| WPRIM
| ID: wpr-59652
ABSTRACT
Tuberculosis (TB) is one of the largest health problems in the world today. And the incidence of nontuberculous mycobacteria (NTM) lung disease appears to be increasing worldwide. Recently, an automated, nucleic acid amplification assay for the rapid detection of both Mycobacterium tuberculosis and rifampin resistance was developed (Xpert MTB/RIF). And fixed-dose combinations of anti-TB drugs and linezolid have been introduced in the treatment of TB. And new NTM species, named Mycobacterium massiliense, which is very closely related to Mycobacterium abscessus was reported. In this review, these recent advances in the diagnosis and treatment of TB and clinical characteristics of M. massiliense lung disease are discussed.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Rifampin
/
Tuberculosis
/
Incidencia
/
Oxazolidinonas
/
Técnicas de Amplificación de Ácido Nucleico
/
Linezolid
/
Pulmón
/
Enfermedades Pulmonares
/
Acetamidas
/
Mycobacterium
Tipo de estudio:
Estudio de incidencia
/
Estudio pronóstico
Idioma:
Inglés
Revista:
Tuberculosis and Respiratory Diseases
Año:
2013
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS